Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $727.83 | 41 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valeant Pharmaceuticals North America LLC | $161.36 | 8 | $0 (2017) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $128.09 | 7 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $118.72 | 7 | $0 (2022) |
| Aerie Pharmaceuticals, Inc. | $77.66 | 5 | $0 (2019) |
| Allergan, Inc. | $71.18 | 4 | $0 (2020) |
| Shire North American Group Inc | $60.59 | 4 | $0 (2018) |
| CooperVision Inc. | $26.29 | 1 | $0 (2018) |
| Dompe US, Inc. | $20.89 | 1 | $0 (2021) |
| ABBVIE INC. | $17.01 | 1 | $0 (2022) |
| Horizon Therapeutics plc | $16.17 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $32.06 | 2 | Horizon Therapeutics plc ($16.17) |
| 2022 | $39.42 | 2 | Novartis Pharmaceuticals Corporation ($22.41) |
| 2021 | $34.94 | 2 | Dompe US, Inc. ($20.89) |
| 2020 | $17.33 | 1 | Allergan, Inc. ($17.33) |
| 2019 | $115.54 | 7 | Novartis Pharmaceuticals Corporation ($49.50) |
| 2018 | $235.06 | 13 | Bausch & Lomb, a division of Bausch Health US, LLC ($114.04) |
| 2017 | $253.48 | 14 | Valeant Pharmaceuticals North America LLC ($161.36) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: TEPEZZA | ||||||
| 09/29/2023 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Ophthalmology | ||||||
| 10/28/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/26/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/18/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | INFUSE (Device) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Ophthalmology | ||||||
| 05/27/2021 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: SOLUTION/ DROPS | ||||||
| 01/09/2020 | Allergan, Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/05/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/27/2019 | Aerie Pharmaceuticals, Inc. | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Glaucoma | ||||||
| 06/20/2019 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/16/2019 | Aerie Pharmaceuticals, Inc. | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Glaucoma | ||||||
| 02/28/2019 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/07/2019 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/10/2019 | Sun Pharmaceutical Industries Inc. | XELPROS (Drug) | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| Category: Ophthalmology | ||||||
| 12/06/2018 | CooperVision Inc. | Multiple Brands Contact Lens (Device) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: Devices | ||||||
| 11/15/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: OPTHALMICS | ||||||
| 10/22/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | ULTRA (Device) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/04/2018 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/02/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | ULTRA (Device) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/23/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Ophthalmology | ||||||
| 08/03/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Ophthalmology | ||||||
| 06/21/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Ophthalmology | ||||||
| 05/28/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | ULTRA (Device) | Food and Beverage | In-kind items and services | $35.44 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/09/2018 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/28/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | ULTRA (Device) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 259 | 290 | $45,099 | $16,350 |
| 2022 | 8 | 296 | 361 | $53,028 | $18,548 |
| 2021 | 9 | 315 | 391 | $57,468 | $20,566 |
| 2020 | 9 | 356 | 424 | $61,133 | $21,606 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 54 | 55 | $9,900 | $4,596 | 46.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 34 | 34 | $6,800 | $3,133 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 49 | $6,125 | $2,976 | 48.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 26 | 40 | $6,400 | $2,486 | 38.8% |
| 92250 | Photography of the retina | Office | 2023 | 50 | 52 | $8,320 | $1,430 | 17.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 21 | 22 | $3,520 | $943.92 | 26.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 16 | 17 | $2,900 | $392.56 | 13.5% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 20 | 21 | $1,134 | $391.51 | 34.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 62 | 63 | $11,340 | $5,233 | 46.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 43 | 72 | $11,520 | $4,432 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 48 | $6,000 | $2,860 | 47.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 19 | 19 | $3,800 | $1,787 | 47.0% |
| 92250 | Photography of the retina | Office | 2022 | 61 | 66 | $10,560 | $1,640 | 15.5% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 28 | 33 | $5,280 | $1,377 | 26.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 24 | 28 | $2,800 | $629.28 | 22.5% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 27 | 32 | $1,728 | $590.10 | 34.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 68 | 70 | $12,600 | $4,699 | 37.3% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 34 | 64 | $10,240 | $4,316 | 42.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 62 | $7,750 | $3,935 | 50.8% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 25 | 25 | $5,000 | $2,427 | 48.5% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 30 | 36 | $5,760 | $1,822 | 31.6% |
| 92250 | Photography of the retina | Office | 2021 | 59 | 66 | $10,560 | $1,515 | 14.3% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 24 | 27 | $2,700 | $748.26 | 27.7% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Office | 2021 | 24 | 27 | $1,458 | $619.32 | 42.5% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 11 | 14 | $1,400 | $482.62 | 34.5% |
About Dr. Benjamin Klibanoff, OD
Dr. Benjamin Klibanoff, OD is a Optometrist healthcare provider based in Pawtucket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2010. The National Provider Identifier (NPI) number assigned to this provider is 1053611996.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Klibanoff, OD has received a total of $727.83 in payments from pharmaceutical and medical device companies, with $32.06 received in 2023. These payments were reported across 41 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($727.83).
As a Medicare-enrolled provider, Klibanoff has provided services to 1,226 Medicare beneficiaries, totaling 1,466 services with total Medicare billing of $77,071. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Other Specialties Optometrist
- Location Pawtucket, RI
- Active Since 10/26/2010
- Last Updated 04/12/2016
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053611996
Products in Payments
- ULTRA (Device) $275.40
- XIIDRA (Drug) $100.71
- TRAVATAN Z (Drug) $78.60
- Rhopressa (Drug) $46.40
- COMBIGAN (Drug) $38.13
- RESTASIS (Drug) $33.05
- Rocklatan (Drug) $31.26
- Multiple Brands Contact Lens (Device) $26.29
- OXERVATE (Drug) $20.89
- VUITY (Drug) $17.01
- TEPEZZA (Drug) $16.17
- TOTAL30 (Device) $15.89
- INFUSE (Device) $14.05
- XELPROS (Drug) $13.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Pawtucket
David Klibanoff
Optometrist — Payments: $1,147
Mona Klibanoff, O.d, O.D
Optometrist — Payments: $360.06
Dr. Jonathan Kaplan, O.d, O.D
Optometrist — Payments: $304.45
Anne Kiernan, Od, OD
Optometrist — Payments: $102.58
Dr. Jillian Libby, Od, OD
Optometrist — Payments: $100.02
Catherine Parris, O.d, O.D
Optometrist — Payments: $90.00